Hedge fund Elliott International is pushing U.S. drugs wholesale group McKesson to hike its $8.3 billion offer for German peer Celesio , a source close to the investor said. McKesson’s offer undervalues Celesio in Elliott’s eyes, the person added. Elliott, run by U.S. investor Paul E. Singer, has spent roughly 800 million euros building a stake of more than 20 percent in Celesio over recent weeks and is now in a position where it can block the takeover.
Help employers find you! Check out all the jobs and post your resume.
